Zenotech Laboratories Ltd

532039

Summary

Fair Value Assessment
Undervalued (19% Discount)
Fair ValueQ65.90UncertaintyHigh
Close Price52.94Mar 26, 2025
52.52
Price Down by 0.42 | 0.79 %
Previous Close
52.94
Day Range
52.00 – 54.50
Year Range
51.00 – 107.79
Bid / Ask
52.54 × 54.06
Market Cap
3.2 Bil
Volume / Average
3.8 k / 11.1 k
Beta (5-Year)
1.32
Shares Outstanding
61.03 Mil
Primary Exchange
Bombay Stock Exchange

Business Description
Zenotech Laboratories Ltd is an India-based pharmaceutical company. It is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing biotechnology products. The Company’s injectables product portfolio primarily serves niche therapy areas like oncology and anesthesiology. It also manufactures products such as granulocyte-colony stimulating factor (GCSF) and Granulocyte-macrophage colony-stimulating factor (GMCSF). The company earns a vast majority of the revenue from the sale of its contract research and manufacturing services.
Contact
Survey No. 250-252 Turkapally Village, Shamirpet Mandal, Hyderabad, TG 500 078
T +91 9032044584
zenotechlab.com opens in a new tab
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Most Recent Earnings
Dec 31, 2024
Fiscal Year End
Mar 31, 2025
Employees
208

Key Metrics

Income Statement (in Mil, except ratios)
12/31/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Revenue
359.52 367.62 383.53 324.94 193.73 259.38
Revenue Growth %
-6.93% -4.15% 18.03% 67.72% -25.31% 99.08%
Gross Profit
313.34 325.57 347.81 299.40 169.82 231.45
Gross Profit Margin %
87.16% 88.56% 90.69% 92.14% 87.65% 89.23%
Operating Income
14.91 61.04 94.60 64.19 -31.48 40.53
Operating Margin %
4.15% 16.60% 24.67% 19.75% -16.25% 15.63%
EBIT
79.33 101.96 142.46 110.18 2.78 107.33
EBIT Margin %
22.06% 27.74% 37.14% 33.91% 1.43% 41.38%
EBITDA
148.99 172.82 214.19 179.91 67.34 155.83
EBITDA Margin %
41.44% 47.01% 55.85% 55.37% 34.76% 60.08%
Net Income
49.89 82.99 115.85 221.76 -12.15 107.78
Net Profit Margin %
13.88% 22.57% 30.21% 68.25% -6.27% 41.55%
Basic EPS
0.82 1.36 1.90 3.63 -0.20 1.77
Diluted EPS
0.82 1.36 1.90 3.63 -0.20 1.77
Normalized EPS
Total Dividends per Share
Balance Sheet (in Mil, except ratios)
09/30/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Total Assets
1,079.23 1,062.06 1,008.73 940.84 858.44 855.54
Total Liabilities
147.58 156.65 186.03 234.44 374.36 359.25
Total Debt
60.00 206.56 186.56
Total Equity
931.65 905.42 822.70 706.40 484.08 496.29
Cash And Cash Equivalents
19.04 18.16 111.42 24.15 24.58 10.82
Working Capital
178.31 126.40 -3.42 -82.01 -76.01 -297.29
Shares Outstanding (Mil)
61.03 61.03 61.03
Book Value Per Share
14.84 13.48 11.57 7.93 8.13
Total Debt To Equity
0.08 0.43 0.38
Cash Flow Statement (in Mil, except ratios)
09/30/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Cash From Operating Activities
95.14 118.23 206.64 176.67 57.41 113.79
Cash From Investing Activities
-229.08 -211.55 -58.24 -18.39 -48.18 -207.93
Cash From Financing Activities
-61.12 -158.71 4.53 -27.01
Capital Expenditures
42.34 62.32 19.38 49.12 217.47
Free Cash Flow
120.02 138.26 137.60 -1.33 -140.48
Change in Cash
-133.94 -93.32 87.28 -0.43 13.76 -121.14

Profile

There is no Key Executive Team data available.
Transaction History

Shares in Thousands
0 5 10 15 20 25 30 35 40
>
No Data Available
There is no available information for this investment.
Sep
2023
    • Buy
    • Acquisition
    • Option Exercise
    • Disposition
    • Sell
Transaction Detail
No Data Available
There is no available information for this investment.

Ownership

There is no Ownership data available.

© Copyright 2025 Morningstar, Inc. All rights reserved.
Terms of Use    Privacy Policy
© Copyright 2025 Morningstar, Inc. All rights reserved. Please read our Terms of Use above. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
As of December 1st, 2023, the ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar/Sustainalytics accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
Company: Morningstar India Private Limited; Regd. Office: 9th floor, Platinum Technopark, Plot No. 17/18, Sector 30A, Vashi, Navi Mumbai – 400705, Maharashtra, India; CIN: U72300MH2004PTC245103; Telephone No.: +91-22-61217100; Fax No.: +91-22-61217200; Contact: Morningstar India Help Desk (e-mail: helpdesk.in@morningstar.com) in case of queries or grievances.
Top